Cargando…
A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
Patients with triple receptor-negative breast cancer often develop aggressive metastatic disease, which also might involve the brain. In many cases, systemic and local treatment is needed. It is important to consider the toxicity of chemo- and radiotherapy, especially when newly approved drugs becom...
Autores principales: | Nieder, Carsten, Aandahl, Gro, Dalhaug, Astrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431070/ https://www.ncbi.nlm.nih.gov/pubmed/22953094 http://dx.doi.org/10.1155/2012/537183 |
Ejemplares similares
-
Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
por: Nieder, Carsten, et al.
Publicado: (2013) -
Correlation between article download and citation figures for highly accessed articles from five open access oncology journals
por: Nieder, Carsten, et al.
Publicado: (2013) -
Presentation and course of brain metastases from breast cancer in a paranoid-schizophrenic patient: A case report
por: Dalhaug, Astrid, et al.
Publicado: (2008) -
Palliative Radiotherapy with or without Additional Care by a Multidisciplinary Palliative Care Team: A Retrospective Comparison
por: Nieder, Carsten, et al.
Publicado: (2014) -
Independent External Validation of a Score Predicting Survival After Radiotherapy for Bone Metastases and Expansion to Patients Treated With Single Fraction Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)